HD-OPM Archive
Topics › Supplements & vitamins

Nattokinase 10,800 FU/day improved carotid plaque and lipids; 3,600 FU/day did not

Gokhan Can · Nov 17, 2023 · ♥ 10 reactions · 7 comments · original Facebook post
Supplements & vitaminsPlaque, CAC & CT angiography
AI summary & key facts

Quotes a clinical study of 1,062 participants in which nattokinase at 10,800 FU/day managed atherosclerosis and hyperlipidemia, shrinking carotid intima-media thickness and plaque size. The lower dose of 3,600 FU/day was ineffective.

Nattokinase

We found that Nattokinase (NK) at a dose of 10,800 FU/day effectively managed the progression of atherosclerosis and hyperlipidemia with a significant improvement in the lipid profile. A significant reduction in the thickness of the carotid artery intima-media and the size of the carotid plaque was observed. The improvement rates ranged from 66.5 to 95.4%. NK was found to be ineffective in lowering lipids and suppressing atherosclerosis progression at a dose of 3,600 FU/day.

Paper · Front Cardiovasc Med · 2022Effective management of atherosclerosis progress and hyperlipidemia with nattokinase: A clinical study with 1,062 participants.Nattokinase (NK), known as a potent fibrinolytic and antithrombotic agent, has been shown to have antiatherosclerotic and lipid-lowering effects. However, data on human clinical studies are limited. In this clinical study involving 1,062 participants, our objective was to examine the efficacy of NK in atherosclerosis and hyperlipidemia and safety at the dose of 10,800 FU/day after 12 months of oral administration.…ncbi.nlm.nih.gov

Research cited

#nattokinase#carotid#plaque#atherosclerosis
← newer: Meta-analysis: lowering LDL with statins had no effect on caolder: What to do with a high coronary calcium CT result: Joel Kahn →